These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4403391)

  • 1. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyramine-induced modifications of ventricular fibrillation thresholds in the dog: influence of sympatholytic agents.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):253-61. PubMed ID: 4125092
    [No Abstract]   [Full Text] [Related]  

  • 3. The anti-arrhythmic action of bretylium in normal reserpine-pretreated and chronically denervated dog hearts.
    Cervoni P; Ellis CH; Maxwell RA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):91-102. PubMed ID: 5551205
    [No Abstract]   [Full Text] [Related]  

  • 4. Catecholamine stores and the negative inotropic effect of beta-adrenergic blocking drugs on the isolated rabbit heart.
    Levy JV
    Arch Int Physiol Biochim; 1967 Jun; 75(3):381-404. PubMed ID: 4167703
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of anti-adrenergic drugs on the concentration of adenylic nucleotides in rabbit myocardia].
    Chekman IS; Tumanov VA
    Farmakol Toksikol; 1973; 36(5):548-50. PubMed ID: 4150862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].
    Takenaka F; Takeya N
    Nihon Rinsho; 1969 Oct; 27(10):2470-8. PubMed ID: 4390982
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of vasodepressor responses to adrenaline by drugs.
    Rajapurkar MV; Sharma ML; Dashputra PG; Jayaswal CL
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):283-9. PubMed ID: 4378731
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of antiarrhythmic and -receptor blocking drugs on functional refractory period and contractility of electrically stimulated guinea-pig atria].
    Reuter N; Heeg E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):323-33. PubMed ID: 4402232
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H; Igarashi T
    Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of action of adrenergic beta-receptor blocking agents in the prevention of cyclopropane adrenaline-evoked ventricular arrhythmias in the dog.
    Sharma PL; Narang RS
    Indian J Med Res; 1968 Aug; 56(8):1256-64. PubMed ID: 5711605
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist.
    Pendleton RG; Petta JM; Hahn RA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism for the reduction in pulmonary resistance induced by halothane.
    Klide AM; Aviado DM
    J Pharmacol Exp Ther; 1967 Oct; 158(1):28-35. PubMed ID: 4383243
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of ventricular fibrillation during hypothermia with bretylium tosylate.
    Buckley JJ; Bosch OK; Bacaner MB
    Anesth Analg; 1971; 50(4):587-93. PubMed ID: 5105113
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 17. A kinetic study of the effects of sympatholytic agents on the responses to field stimulation in guinea-pig atrium.
    Ban T; Fujiwara M
    Arzneimittelforschung; 1973 Dec; 23(12):1716-20. PubMed ID: 4150213
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic drugs: electrophysiological actions.
    Bassett AL; Hoffman BF
    Annu Rev Pharmacol; 1971; 11():143-70. PubMed ID: 4402439
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):241-3. PubMed ID: 4242393
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of ventricular fibrillation induced by coronary ligation.
    Kaumann AJ; Aramendía P
    J Pharmacol Exp Ther; 1968 Dec; 164(2):326-32. PubMed ID: 5699094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.